Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr;11(Suppl 5):S735-S742.
doi: 10.21037/jtd.2018.11.104.

Robot-assisted minimally invasive esophagectomy (RAMIE) improves perioperative outcomes: a review

Affiliations
Review

Robot-assisted minimally invasive esophagectomy (RAMIE) improves perioperative outcomes: a review

B Feike Kingma et al. J Thorac Dis. 2019 Apr.

Abstract

Robotic assisted minimal invasive esophagectomy (RAMIE) is increasingly applied as a clinically and oncologically safe technique in the surgical treatment of esophageal cancer. This review focuses on the advantages and potential opportunities of RAMIE to improve the perioperative and oncological outcomes based on the evidence from current literature. In addition, critical notes on aspects such as procedure duration and costs are addressed in this paper.

Keywords: Robotic surgery; enhanced recovery after surgery (ERAS); esophagectomy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: R van Hillegersberg and JP Ruurda are proctors for Intuitive Surgical Inc. (Sunnyvale, California, USA). Other authors have no conflicts of interest to declare.

References

    1. Shapiro J, van Lanschot JJ, Hulshof MC, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 2015;16:1090-8. 10.1016/S1470-2045(15)00040-6 - DOI - PubMed
    1. Goense L, van der Sluis PC, van Rossum PSN, et al. Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival. J Surg Oncol 2017;115:812-20. 10.1002/jso.24596 - DOI - PubMed
    1. Visser E, Leeftink AG, van Rossum PS, et al. Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer. Ann Surg Oncol 2016;23:2679-89. 10.1245/s10434-016-5191-6 - DOI - PMC - PubMed
    1. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-9. 10.1056/NEJMoa022343 - DOI - PubMed
    1. Findlay JM, Tustian E, Millo J, et al. The effect of formalizing enhanced recovery after esophagectomy with a protocol. Dis Esophagus 2015;28:567-73. 10.1111/dote.12234 - DOI - PubMed